Assure Holdings Corp. (NASDAQ:IONM) Short Interest Update

Assure Holdings Corp. (NASDAQ:IONMGet Rating) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 2,900 shares, a drop of 54.0% from the April 15th total of 6,300 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 7,500 shares, the days-to-cover ratio is currently 0.4 days.

IONM has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Assure from a “sell” rating to a “hold” rating in a research report on Thursday, January 20th. Benchmark assumed coverage on shares of Assure in a research note on Tuesday, April 5th. They set a “buy” rating and a $9.00 price target on the stock.

A hedge fund recently bought a new stake in Assure stock. Manatuck Hill Partners LLC acquired a new position in Assure Holdings Corp. (NASDAQ:IONMGet Rating) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 62,500 shares of the company’s stock, valued at approximately $377,000. Manatuck Hill Partners LLC owned approximately 0.53% of Assure at the end of the most recent quarter. Institutional investors and hedge funds own 1.26% of the company’s stock.

IONM stock remained flat at $$3.01 during midday trading on Friday. 10,786 shares of the company’s stock were exchanged, compared to its average volume of 7,306. Assure has a 1 year low of $2.71 and a 1 year high of $11.35. The stock has a market capitalization of $38.89 million, a PE ratio of -13.68 and a beta of 1.44. The company has a debt-to-equity ratio of 0.47, a quick ratio of 10.22 and a current ratio of 10.22. The stock’s 50 day moving average price is $5.11 and its 200-day moving average price is $5.25.

Assure (NASDAQ:IONMGet Rating) last issued its quarterly earnings data on Monday, March 14th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). The company had revenue of $9.66 million for the quarter, compared to analyst estimates of $8.90 million. Assure had a negative return on equity of 11.57% and a negative net margin of 9.44%. During the same quarter in the previous year, the business earned ($0.05) earnings per share. Analysts predict that Assure will post -0.06 earnings per share for the current year.

Assure Company Profile (Get Rating)

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.

Further Reading

Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.